Glucose uptake |
In vitro study |
HepG2 cells/primary mouse hepatocytes |
NaHS (10, 30 and 100 μM)/– |
Inhibited |
[32] |
|
Glycogen storage |
In vitro study |
HepG2 cells |
NaHS (10, 30 and 100 μM) |
Inhibited |
[32] |
In vivo study |
Liver from mice under nonfastingor 6-h fasting condition |
– |
Inhibited |
[32] |
|
Gluconeogenesis |
In vitro study |
HepG2 cells/primary mouse hepatocytes |
NaHS (10, 30 and100 μM)/– |
Promoted |
[32] |
|
Primary mouse hepatocytes |
NaHS (30 μM) |
Promoted |
[33] |
|
HepG2 cells/primary mouse hepatocytes |
NaHS (50 μM)/– |
Promoted |
[34] |
|
HepG2 cells/primary mouse hepatocytes |
NaHS (100 μM)/– |
Inhibited |
[35] |
|
In vivo study |
Pyruvate tolerance test on overnight-fasted mice |
NaHS (39 and 63 μM/kg) |
Promoted |
[33] |
|
Pyruvate tolerance test on high fat diet-fed mice |
NaHS (50 μM/kg/day) |
Inhibited |
[35] |
|
Mitochondrial function |
Biogenesis |
Primary moue hepatocytes |
NaHS (30 μM) |
Promoted |
[38] |
Bioenergetics |
HepG2 cells |
NaHS (0.01 and 0.1 μM) |
Promoted |
[39] |